Company: OSRH
Filing Date: 2025-08-29
Form Type: DEF 14A
Source: 0001213900-25-082061
Chunk: 16

Company: OSR Holdings, Inc.
Filing Date: 2025-08-29
Form: DEF 14A
Chunk 16
---
 in the case of Reto Fierz, for which he is being nominated) along with their age as of the Record Date. Proxies which are received unmarked but not marked to the contrary will be voted in favor of each such Nominee’s election, pro ratawith the percentage of marked proxy votes otherwise cast for such Nominee.

| Name            |     | Age |     | Position                             |
| Kuk Hyoun Hwang |     |  50 |     | Chief Executive Officer and Director |
| Jun Chul Whang  |     |  61 |     | Chief Legal Officer and Director     |
| Alcide Barberis |     |  67 |     | Independent Director                 |
| Seng Chin Mah   |     |  66 |     | Independent Director                 |
| Jin Whan Park   |     |  57 |     | Independent Director                 |
| Phil Geon Lee   |     |  58 |     | Independent Director                 |
| Hyuk Joo Jee    |     |  58 |     | Independent Director                 |
| Joong Myung Cho |     |  75 |     | Independent Director                 |
| Reto Fierz      |     |  56 |     | Nominee                              |

Kuk Hyoun Hwanghas been the Chief Executive Officer and a director of OSR since March 2020. Mr. Hwang is also the President and Chief Executive Officer of the Company as of the Closing of the Business Combination. Mr. Hwang is the Managing Partner of BCM, which he founded in August 2012. Since then, he has led BCM’s and its subsidiaries’ growth and expansion as a cross -borderhealthcare investment group in three countries: the U.S., South Korea and Switzerland. He is also the Chief Executive Officer of BCME, a position he has held since March 2020, and the Chairman of the Board of Vaximm AG since November 2022. Since July 2019 until April 2021 and December 2022 to August 2024, Mr. Hwang has also served as Chief Executive Officer of OSR, a global drug development company and a subsidiary of BCM, where he has also served as chairman since July 2019. Prior to founding BCM in 2012, Mr. Hwang served with financial services firms in Korea and the U.S., including North Head Capital Partners LLC from 2011 -2012, Kim Eng Research Korea and Kim Eng